Aurinia Pharmaceuticals Inc. financial data

Symbol
AUPH on Nasdaq
Location
#140, 14315 118 Avenue, Edmonton, Alberta, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 530 % -3.75%
Quick Ratio 55.1 % +6.6%
Debt-to-equity 46 % +5.8%
Return On Equity 21.8 %
Return On Assets 14.9 %
Operating Margin 26.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 132M shares -7.92%
Common Stock, Shares, Outstanding 132M shares -7.87%
Entity Public Float 800M USD -42%
Weighted Average Number of Shares Outstanding, Basic 132M shares -7.86%
Weighted Average Number of Shares Outstanding, Diluted 136M shares -6.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 266M USD +20.6%
Cost of Revenue 29.4M USD +4.72%
Research and Development Expense 29.7M USD +29.7%
General and Administrative Expense 110M USD -40.8%
Costs and Expenses 196M USD -22.6%
Operating Income (Loss) 70M USD +153%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 79.6M USD +116%
Income Tax Expense (Benefit) 1.8M USD -25.2%
Net Income (Loss) Attributable to Parent 77.8M USD +120%
Earnings Per Share, Basic 0 USD/shares +140%
Earnings Per Share, Diluted 0 USD/shares +130%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 72.9M USD +99%
Inventory, Net 44.8M USD +15.7%
Other Assets, Current 301K USD -88.9%
Assets, Current 439M USD -0.39%
Property, Plant and Equipment, Net 2.27M USD -21.5%
Operating Lease, Right-of-Use Asset 3.72M USD -11%
Other Assets, Noncurrent 93K USD -89.3%
Assets 528M USD -3.97%
Accounts Payable, Current 2.21M USD
Employee-related Liabilities, Current 9.76M USD -31.2%
Accrued Liabilities, Current 49.5M USD
Contract with Customer, Liability, Current 4.6M USD +6.92%
Liabilities, Current 76.2M USD -3.04%
Operating Lease, Liability, Noncurrent 5.12M USD -14%
Other Liabilities, Noncurrent 12.4M USD +14.3%
Liabilities 162M USD +0.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax -749K USD -94.5%
Retained Earnings (Accumulated Deficit) -860M USD +8.3%
Stockholders' Equity Attributable to Parent 366M USD -5.73%
Liabilities and Equity 528M USD -3.97%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.3M USD
Net Cash Provided by (Used in) Financing Activities -49.3M USD -228%
Net Cash Provided by (Used in) Investing Activities 31M USD -37%
Common Stock, Shares, Issued 132M shares -7.87%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -17M USD -209%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 73.2M USD +97.1%
Deferred Tax Assets, Valuation Allowance 154M USD -4.61%
Deferred Tax Assets, Gross 169M USD -7.67%
Operating Lease, Liability 6.18M USD -11.4%
Depreciation 4.85M USD +576%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 77.5M USD +114%
Lessee, Operating Lease, Liability, to be Paid 7.18M USD -13.7%
Property, Plant and Equipment, Gross 5.26M USD 0%
Operating Lease, Liability, Current 1.06M USD +3.83%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.2M USD +2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17M USD +2.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.01M USD -25.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.23M USD +2.34%
Deferred Tax Assets, Operating Loss Carryforwards 130M USD -5.63%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.22M USD -0.33%
Operating Lease, Payments 276K USD +4.94%
Amortization of Intangible Assets 900K USD +12.5%
Depreciation, Depletion and Amortization 4.86M USD +0.19%
Deferred Tax Assets, Net of Valuation Allowance 14.1M USD -31.6%
Share-based Payment Arrangement, Expense 5.92M USD -28.9%
Interest Expense 5.19M USD +1743%